Cargando…
Outsmarting cancer: the power of hybrid genomic/proteomic biomarkers to predict drug response
A recent study by Niepel and colleagues describes a novel approach to predicting response to targeted anti-cancer therapies. The authors used biochemical profiling of signaling activity in basal and ligand-stimulated states for a panel of receptor and intracellular kinases to develop predictive mode...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053204/ https://www.ncbi.nlm.nih.gov/pubmed/25032256 http://dx.doi.org/10.1186/bcr3635 |